SCHEMBL9522069

SCHEMBL9522069

CCCCC/C(=C/C=C/C(=O)N[C@H](C)CCCc1cccnc1)c1cccc(F)c1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10397805 1.00 PTAFR (0.77) PTAFR
SCHEMBL9520317 1.00 PTAFR (0.77) PTAFR
SCHEMBL9519909 0.91 PTAFR (0.82) PTAFR
SCHEMBL9521161 0.91 PTAFR (0.81) PTAFR
SCHEMBL10398953 0.91 PTAFR (0.81) PTAFR
SCHEMBL9522432 0.90 PTAFR (0.73) PTAFR
SCHEMBL10672780 0.90 PTAFR (0.81) PTAFR
SCHEMBL9520623 0.90 PTAFR (0.81) PTAFR
SCHEMBL9520582 0.87 PTAFR (1.00) PTAFR
SCHEMBL10397680 0.87 PTAFR (1.00) PTAFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299379-B1 PENTADIENAMIDE PAF-ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1993-04-21 EP disclosed
US-4975438-A ANTICOAGULANT HOFFMANN-LA ROCHE INC. (US) 1990-12-04 US disclosed
EP-0299379-A1 Pentadienamide PAF-antagonists F. HOFFMANN-LA ROCHE AG (CH) 1989-01-18 EP disclosed
US-4788206-A CARDIOVASCULAR DISORDERS, PLATELETS HOFFMANN-LA ROCHE INC. (US) 1988-11-29 US disclosed